Publication of Phase II trial results of NGR-hTNF in liver cancer by the British Journal of Cancer
Prometheus Launches the First Serogenetic Test to Predict Risk of Complications from Crohn's Disease
Clients in focus...
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us